Cargando…

Insulin-like growth factor 1 reduces coronary atherosclerosis in pigs with familial hypercholesterolemia

Although murine models of coronary atherosclerotic disease have been used extensively to determine mechanisms, limited new therapeutic options have emerged. Pigs with familial hypercholesterolemia (FH pigs) develop complex coronary atheromas that are almost identical to human lesions. We reported pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sukhanov, Sergiy, Higashi, Yusuke, Yoshida, Tadashi, Danchuk, Svitlana, Alfortish, Mitzi, Goodchild, Traci, Scarborough, Amy, Sharp, Thomas, Jenkins, James S., Garcia, Daniel, Ivey, Jan, Tharp, Darla L., Schumacher, Jeffrey, Rozenbaum, Zach, Kolls, Jay K., Bowles, Douglas, Lefer, David, Delafontaine, Patrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990768/ https://www.ncbi.nlm.nih.gov/pubmed/36602878 http://dx.doi.org/10.1172/jci.insight.165713

Ejemplares similares

Insulin-Like Growth Factor I Prevents Cellular Aging via Activation of Mitophagy
por: Hou, Xuwei, et al.
Publicado: (2020)

Reply: Tolerating Large Preclinical Models of HFpEF But Without the Intolerance?
por: Sharp, Thomas E., et al.
Publicado: (2021)

Angiotensin II Infusion Induces Marked Diaphragmatic Skeletal Muscle Atrophy
por: Rezk, Bashir M., et al.
Publicado: (2012)

Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and function
por: Tabony, Alexander Michael, et al.
Publicado: (2014)

Endurance exercise training does not limit coronary atherosclerosis in familial hypercholesterolemic swine
por: Tharp, Darla L., et al.
Publicado: (2019)

Novel Göttingen Miniswine Model of Heart Failure With Preserved Ejection Fraction Integrating Multiple Comorbidities
por: Sharp, Thomas E., et al.
Publicado: (2021)

Soluble urokinase plasminogen activator receptor: from biomarker to active participant in atherosclerosis and cardiovascular disease
por: Goodchild, Traci T., et al.
Publicado: (2022)

Efficacy of a Novel Mitochondrial-Derived Peptide in a Porcine Model of Myocardial Ischemia/Reperfusion Injury
por: Sharp, Thomas E., et al.
Publicado: (2020)

K(Ca)3.1 Inhibition Decreases Size and Alters Composition of Atherosclerotic Lesions Induced by Low, Oscillatory Flow
por: Tharp, Darla L., et al.
Publicado: (2021)

Combined Angiotensin Receptor–Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure
por: Trivedi, Rishi K., et al.
Publicado: (2018)

Upregulation of Intermediate-Conductance Ca(2+)-Activated K(+) Channels (KCNN4) in Porcine Coronary Smooth Muscle Requires NADPH Oxidase 5 (NOX5)
por: Gole, Hope K. A., et al.
Publicado: (2014)

Serum Metabolomics Reveals Distinct Profiles during Ischemia and Reperfusion in a Porcine Model of Myocardial Ischemia–Reperfusion
por: Goetzman, Eric, et al.
Publicado: (2022)

Radiofrequency Renal Denervation Protects the Ischemic Heart via Inhibition of GRK2 and Increased Nitric Oxide Signaling
por: Polhemus, David J., et al.
Publicado: (2016)

Nonlethal Inhibition of Gut Microbial Trimethylamine N‐oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure
por: Organ, Chelsea L., et al.
Publicado: (2020)

Zofenopril Protects Against Myocardial Ischemia–Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability
por: Donnarumma, Erminia, et al.
Publicado: (2016)

Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a “2‐Hit” Murine Model
por: LaPenna, Kyle B., et al.
Publicado: (2023)

Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFβ1
por: Sosulski, Meredith L, et al.
Publicado: (2015)

Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy
por: Yoshida, Tadashi, et al.
Publicado: (2020)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway
por: Saito, Shigeki, et al.
Publicado: (2017)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Cardiometabolic Heart Failure and HFpEF: Still Chasing Unicorns
por: Sharp, Thomas E., et al.
Publicado: (2019)

Analytical Validation of Familial Hypercholesterolemia Biomarkers in Dried Blood Spots
por: Held, Patrice K., et al.
Publicado: (2022)

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
por: Tandirerung, Fistra Janrio
Publicado: (2022)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)

Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US
por: Saadatagah, Seyedmohammad, et al.
Publicado: (2022)

Prevalence and Treatment of Familial Hypercholesterolemia and Severe Hypercholesterolemia in Older Adults in Ontario, Canada
por: Akioyamen, Leo E., et al.
Publicado: (2022)

Cigarette smoke represses the innate immune response to asbestos
por: Morris, Gilbert F., et al.
Publicado: (2015)

Meeting Contemporary Challenges: Development of Nanomaterials for Veterinary Medicine
por: Danchuk, Oleksii, et al.
Publicado: (2023)

Mitochondrial Pathobiology and Metabolic Remodeling in Progression to Overt Systolic Heart Failure
por: Chaanine, Antoine H., et al.
Publicado: (2020)

Familial Hypercholesterolemia: The Lipids or the Genes?
por: Fahed, Akl C, et al.
Publicado: (2011)

Familial hypercholesterolemia: A review
por: Varghese, Mithun J
Publicado: (2014)

Familial Hypercholesterolemia and the Atherosclerotic Disease
por: Kim, Yoo Ri, et al.
Publicado: (2013)

The Draupadi of dyslipidemia: Familial hypercholesterolemia
por: Kalra, Sanjay, et al.
Publicado: (2016)

Tendinous xanthoma with familial hypercholesterolemia
por: Roy, Alok Kumar, et al.
Publicado: (2014)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n3dg5qcuhhqpq98hjndog3ulk6